Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The mammary gland is a highly vascularized tissue capable of expansion and regression during development and disease. To enable mechanistic insight into the coordinated morphogenic crosstalk between the epithelium and vasculature, we introduce a 3D microfluidic platform that juxtaposes a human mammary duct in proximity to a perfused endothelial vessel. Both compartments recapitulate stable architectural features of native tissue and the ability to undergo distinct forms of branching morphogenesis. Modeling HER2/ERBB2 amplification or activating PIK3CA(H1047R) mutation each produces ductal changes observed in invasive progression, yet with striking morphogenic and behavioral differences. Interestingly, PI3Kα ducts also elicit increased permeability and structural disorganization of the endothelium, and we identify the distinct secretion of IL-6 as the paracrine cause of PI3Kα-associated vascular dysfunction. These results demonstrate the functionality of a model system that facilitates the dissection of 3D morphogenic behaviors and bidirectional signaling between mammary epithelium and endothelium during homeostasis and pathogenesis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338408PMC
http://dx.doi.org/10.1038/s41467-020-17102-xDOI Listing

Publication Analysis

Top Keywords

mammary duct
8
uncovering mutation-specific
4
morphogenic
4
mutation-specific morphogenic
4
morphogenic phenotypes
4
phenotypes paracrine-mediated
4
paracrine-mediated vessel
4
vessel dysfunction
4
dysfunction biomimetic
4
biomimetic vascularized
4

Similar Publications

Emerging HER2 Targeting Immunotherapy for Cholangiocarcinoma.

Oncol Res

September 2025

Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection & Graduate School of Medical Sciences, Kumamoto University 2-2-1 Honjo, Chuo-ku, Kumamoto, 860-0811, Japan.

Cholangiocarcinoma (CCA) is a fatal bile duct malignancy. CCA is intrinsically resistant to standard chemotherapy, responds poorly to it, and has a poor prognosis. Effective treatments for cholangiocarcinoma remain elusive, and a breakthrough in CCA treatment is still awaited.

View Article and Find Full Text PDF

We present the case of a 67-year-old female who developed simultaneous metastases to the ampulla of Vater and the breast. Her medical history is significant for a radical nephrectomy performed twenty-one years prior for renal cell carcinoma (RCC). The patient was referred for evaluation due to the development of progressive jaundice, fatigue, and weight loss.

View Article and Find Full Text PDF

Development of breast-mimicking phantoms for use in optical coherence elastography.

J Biomed Opt

December 2025

The University of Western Australia, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands and Centre for Medical Research, BRITElab, Perth, Western Australia, Australia.

Significance: Optical coherence elastography (OCE) is an emerging technique for mapping tissue mechanical properties into an image, known as an elastogram, with microscale resolution. Although system characterization phantoms are widely used in OCE development, there is a critical need for tissue-mimicking phantoms that can more accurately replicate the complex structural and mechanical properties of tissues, particularly for validating clinical applications, such as in breast cancer.

Aim: We aim to investigate the effects of tissue-like structures on elastogram formation in a controlled environment by developing and characterizing two types of breast tissue-mimicking phantoms, replicating invasive ductal carcinoma (IDC) morphology and the other mimicking breast ductal networks.

View Article and Find Full Text PDF

Rationale: Human epidermal growth factor receptor 2 (HER2)-positive cholangiocarcinoma is a rare disease with a low incidence and high degree of malignancy. Trastuzumab deruxtecan (T-DXd) has been approved for the treatment of HER2-positive breast and gastric cancer. However, it is still in the initial exploration period for HER2-positive cholangiocarcinoma.

View Article and Find Full Text PDF

The BI-RADS 5th Edition recommends that a solitary dilated duct should be assessed as a BI-RADS category 4 lesion and recommended for biopsy. More recently, 3 studies published after the fifth edition of BI-RADS have reported lower rates of malignancy associated with solitary dilated ducts ranging from 0% to 3.4%.

View Article and Find Full Text PDF